NDC 68462-317 – Fulvestrant
Fulvestrant 50 mg/mL · Injection · Intramuscular
Product NDC68462-317
Product details
- Brand name
- Fulvestrant
- Generic name
- Fulvestrant
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Dosage form
- Injection
- Route
- Intramuscular
- Marketing category
- ANDA · ANDA207754
- Marketed since
- August 22, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Estrogen Receptor Antagonist
Active ingredients
- Fulvestrant 50 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 68462-317-32 | 2 SYRINGE, GLASS in 1 CARTON (68462-317-32) / 5 mL in 1 SYRINGE, GLASS (68462-317-40) | Aug 22, 2019 |
Recalls mentioning this NDC
- D-0820-2021 Sep 29, 2021 · Class II
Lack of Assurance of Sterility
Other Fulvestrant products
- 16729-436 Fulvestrant 250 mg/5mL · Injection · Accord Healthcare Inc.
- 62332-650 Fulvestrant 50 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 68001-522 Fulvestrant 250 mg/5mL · Injection · BluePoint Laboratories
- 68001-626 Fulvestrant 50 mg/mL · Injection · BluePoint Laboratories.
- 71731-6121 Fulvestrant 50 mg/mL · Injection · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- 55150-394 Fulvestrant 50 mg/mL · Injection · Eugia US LLC
- 0143-9022 Fulvestrant 50 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 71288-555 Fulvestrant 50 mg/mL · Injection · Meitheal Pharmaceuticals Inc
- 0781-3532 Fulvestrant 50 mg/mL · Injection · Sandoz Inc
- 0781-9055 Fulvestrant 50 mg/mL · Injection · Sandoz Inc
- 70121-1463 Fulvestrant 250 mg/5mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 70860-211 Fulvestrant 50 mg/mL · Injection, Solution · Athenex Pharmaceutical Division, LLC.